Utilizing wearable sensors for continuous monitoring of reactions COVID-19 vaccine

Clinical trial guidelines for assessing the safety of vaccines are primarily based on self-reported questionnaires. Despite the tremendous technological advances in recent years, objective, continuous assessment of physiological measures post-vaccination is rarely performed. We identify continuous and significant changes following vaccine administration in nearly all vitals. The considerably higher sensitivity of wearable sensors can revolutionize clinical trials by enabling earlier identification of abnormal reactions with fewer subjects.


Read the full article here:

https://www.nature.com/articles/s43856-022-00090-y